PROFILE
Professor Vincent Boima is a Professor of Medicine and Nephrology and Head of the Department of Medicine and Therapeutics at the University of Ghana Medical School. His career has been dedicated to improving the prevention, diagnosis and management of chronic kidney disease (CKD) through research, clinical practice and health systems strengthening. With extensive training in nephrology, public health and research methodology, he has made significant contributions to understanding CKD, hypertension and other non-communicable diseases in Africa, while advancing patient-centred care through studies on mental health, organ transplantation, genetics and healthcare delivery.
Beyond his clinical and research work, Professor Boima has provided distinguished leadership in medical education, healthcare policy and professional service. He has held several academic and administrative positions at the University of Ghana Medical School and Korle Bu Teaching Hospital, led regional nephrology training initiatives, contributed to national clinical guidelines, and secured competitive research grants supporting kidney disease research across Africa. As a mentor, educator and clinician, he has supervised numerous medical and postgraduate trainees while championing kidney health awareness, community outreach and the strengthening of nephrology services in Ghana.
ABSTRACT
1. The Burden of Chronic Kidney Disease in Africa and Ghana
Chronic kidney disease (CKD) is significantly more prevalent across Africa than in high-income countries, with many patients presenting late and already in advanced stages. Hypertension and diabetes are the primary drivers, and in Ghana, CKD disproportionately affects younger, economically active individuals. Access to life-saving treatments like dialysis and transplantation is limited due to high costs, uneven distribution of services, and low transplant capacity. This raises an important question: could kidney failure have been prevented through earlier and broader interventions? The lecture introduces a “holistic precision nephrology” model for Africa—the Genes–Mind–Community framework, integrating behavioural, community and genomic factors in care. It redefines precision medicine as delivering the right, context-appropriate interventions equitably, with the goal of reducing health disparities.
2. Genes: African‑Led Genomics and Responsible Precision Medicine
The third pillar explores the promise and complexity of genomics, focusing particularly on APOL1 risk variants, which are prevalent in West Africa and linked to increased risk of non‑diabetic CKD when triggered by “second hits” such as infections, hypertension or environmental exposures. Ghanaian and West African data suggest that a meaningful proportion of individuals carry high‑risk APOL1 genotypes, helping explain the disproportionate kidney‑disease burden among younger African patients. However, the lecture argues that genomic translation must be ethical, equitable and clinically purposeful. Genetic risk information should only be used when it demonstrably improves care decisions and does not exacerbate stigma or inequity. The Genes pillar calls for: 1) Building African cohorts for kidney‑genomics research; 2) Integrating genomic data with environmental, behavioural and clinical factors; 3)Validating affordable biomarkers for early detection of high‑risk individuals; 4) Preparing health systems for the coming era of APOL1‑targeted therapies; 5) Maintaining strong safeguards for fairness, transparency and accessibility. This approach positions African researchers and clinicians at the forefront of context‑appropriate precision medicine.
2. Mind: Psychological Well‑being as a Core Component of Kidney Care
The first pillar underscores that psychological health is not peripheral but central to chronic disease trajectories. The lecture presents evidence of high levels of depression, anxiety and emotional distress among individuals with hypertension, CKD and those on dialysis. In Ghana and similar settings, these psychological burdens interact with financial hardship, inconsistent access to medications and fragmented follow‑up. Untreated psychological distress can worsen adherence, reduce engagement with care and accelerate disease progression.
Consequently, this pillar proposes routine psychological screening in hypertension and kidney clinics, using culturally sensitive tools and brief evidence‑based interventions. It calls for integrating mental‑health support into chronic‑disease management rather than treating it as optional. Strengthening coping mechanisms, reducing distress and improving self‑care are positioned as essential strategies to slow CKD progression, especially where formal mental‑health services remain limited.
4. Community: Prevention, Access and Continuity as the Highest‑Yield Interventions
The second pillar argues that “Africa cannot dialyse its way out” of the CKD epidemic. Prevention, particularly the detection and control of hypertension is highlighted as the single most scalable and cost‑effective strategy to reduce the downstream burden of kidney failure, stroke and heart failure. Community‑based studies in Ghana demonstrate that large‑scale hypertension screening is feasible and can reveal many previously undiagnosed individuals. However, achieving adequate blood‑pressure control is hindered by barriers such as medication costs, long travel distances, long waiting times and insufficient financial protection. The lecture stresses that community strategies must therefore extend beyond one‑time screenings toward interventions that guarantee continuity of care. Proposed models include: 1) decentralised care through primary‑care networks and community-based services; 2) task‑sharing with trained non‑physician health workers; 3) simplified clinical protocols suited for resource‑limited environments; 4) low‑cost digital supports, including SMS reminders, for populations with uneven smartphone access, and 5) leveraging social capital, including families and faith‑based networks, to strengthen adherence and care continuity. Through these measures, the Community pillar reframes prevention and access as the most impactful levers for improving kidney outcomes, especially in systems where dialysis is expensive, limited and geographically inaccessible.
Health‑System Realities and Policy Implications
Across the three pillars, the lecture situates CKD within Ghana’s current health‑financing and service‑delivery landscape. Dialysis remains the primary Kidney Replacement Therapy (KRT), yet it is costly, concentrated in a few geographic areas and often financed through catastrophic out‑of‑pocket spending. Transplantation capacity remains limited. These constraints reinforce the central thesis: prevention and chronic‑care support must receive priority in policy, financing and service redesign. Key policy directions include: 1) expanding the workforce and formalising task‑sharing strategies; 2) strengthening primary‑care capacity for hypertension and cardiometabolic risk management; 3) ensuring financial protection for essential diagnostics and medicines; 4) establishing registries and data systems to monitor equity, quality and outcomes; 5) investing in mental‑health integration and community‑level prevention and 6) developing a regulatory and ethical framework for APOL1‑informed care
Conclusion: A Vision for African‑Led Precision Kidney Care
The lecture concludes with a call to shift kidney care in Ghana and Africa away from a focus on dialysis centers and toward holistic precision kidney care. The Genes–Mind–Community model reimagines kidney health through genomic insights that are ethically grounded and contextually adapted, psychological support and community‑driven prevention of kidney disease. With coordinated reforms in workforce, financing, primary care and data systems, Africa can lead a new era of equitable precision medicine that treats people, not just kidneys and prevents avoidable progression to kidney failure.